BACKGROUND: Active physical rehabilitation while bridged to lung transplantation with venovenous (VV) extracorporeal membrane oxygenation (ECMO) is an evolving treatment option in adults with limited published experience in pediatric patients. METHODS: The administration of VV ECMO through the placement of a single-site bicaval dual-lumen (BCDL) catheter (Avalon Laboratories, Rancho Dominguez, CA, USA) permits respiratory support in a critically ill patient with avoidance of sedation and paralytics while allowing rehabilitation and oral nutrition. RESULTS: A 13-year-old girl with advanced interstitial lung disease underwent active rehabilitation while being bridged to lung transplantation with single-site VV ECMO. CONCLUSIONS: The innovative use of single-site VV ECMO with a BCDL catheter is transforming the care of adult patients with advanced lung disease and acute respiratory failure as a method to extend the life of a lung transplantation candidate to maximize all opportunities for organ availability. Based on our experiences, clinicians caring for children should be aware of this potential option in pediatric patients requiring lung transplantation.
BACKGROUND: Active physical rehabilitation while bridged to lung transplantation with venovenous (VV) extracorporeal membrane oxygenation (ECMO) is an evolving treatment option in adults with limited published experience in pediatric patients. METHODS: The administration of VV ECMO through the placement of a single-site bicaval dual-lumen (BCDL) catheter (Avalon Laboratories, Rancho Dominguez, CA, USA) permits respiratory support in a critically ill patient with avoidance of sedation and paralytics while allowing rehabilitation and oral nutrition. RESULTS: A 13-year-old girl with advanced interstitial lung disease underwent active rehabilitation while being bridged to lung transplantation with single-site VV ECMO. CONCLUSIONS: The innovative use of single-site VV ECMO with a BCDL catheter is transforming the care of adult patients with advanced lung disease and acute respiratory failure as a method to extend the life of a lung transplantation candidate to maximize all opportunities for organ availability. Based on our experiences, clinicians caring for children should be aware of this potential option in pediatric patients requiring lung transplantation.
Authors: Abeel A Mangi; David P Mason; James J Yun; Sudish C Murthy; Gosta B Pettersson Journal: J Thorac Cardiovasc Surg Date: 2010-04-09 Impact factor: 5.209
Authors: F Schmidt; M Sasse; M Boehne; C Mueller; H Bertram; C Kuehn; G Warnecke; M Ono; K Seidemann; T Jack; H Koeditz Journal: Pediatr Transplant Date: 2012-10-11
Authors: David A Turner; Ira M Cheifetz; Kyle J Rehder; W Lee Williford; Desiree Bonadonna; Scott J Banuelos; Stacey Peterson-Carmichael; Shu S Lin; R Duane Davis; David Zaas Journal: Crit Care Med Date: 2011-12 Impact factor: 7.598
Authors: Christian A Bermudez; Rodolfo V Rocha; Penny L Sappington; Yoshiya Toyoda; Holt N Murray; Arthur J Boujoukos Journal: Ann Thorac Surg Date: 2010-09 Impact factor: 4.330
Authors: Ruslan Natanov; Abdurasul Khalikov; Faikah Gueler; Ulrich Maus; Erin C Boyle; Axel Haverich; Christian Kühn; Nodir Madrahimov Journal: Intensive Care Med Exp Date: 2019-12-16